LISATA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
LISATA THERAPEUTICS, INC. (LSTA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $455.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-02-27
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $455.00K, a 48.00% decline from fiscal 2023.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $875.00K, a 89.83% decline from fiscal 2022.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $8.60M, a 1283.28% increase from fiscal 2021.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was $622.00K, a 12340.00% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $455.00K 10-K · filed 2025-02-27 | |
| 2023-12-31 | $875.00K 10-K · filed 2025-02-27 | $809.00K 10-K · filed 2024-02-29 |
| 2022-12-31 | $8.60M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $622.00K 10-K · filed 2023-03-30 | $320.00K 10-K · filed 2022-03-22 |
| 2020-12-31 | $5.00K 10-K · filed 2022-03-22 | |
| 2019-12-31 | $14.00K 10-K · filed 2021-02-25 | |
| 2018-12-31 | $11.00K 10-K · filed 2020-03-05 | |
| 2017-12-31 | $107.00K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |